IXC invex therapeutics ltd

0.00%

9.0¢

DCF Valuation Model for Invex Therapeutics, page-4

First 4 Last

Share
Profile

Follow
SSilverstein

795 Posts.

45

03/02/23

19:18

Post #: 66062763
Share

Originally posted by CatalystDriven: ↑

Hi All,

Having scrolled through the IXC forum for 18-24 months now, I have seen quite literally 200+ posts of charts discussing the stock price, and only a handful of posts discussing the fundamental analysis of the business itself,

So in a bid to change this and to provoke discussion back to the things that truly matter in investing - the target company fundamentals,

Here is my amateur made DCF Valuation Model for Invex Therapeutics that I have been working on for many, many, many, months.

Result: $6.19 Intrinsic Value

PLEASE NOTE:
I am NOT a professional, DO NOT USE this material as a reason to invest in the stock, or share to anyone without this disclaimer, always consult a licensed finance professional before investing. I am only an amateur, while I am a keen one, I would have bound to have made mistakes in this model. As an amateur investor who is keen to know how biotech stocks are valued I have had a stab at IXC above, do not treat it as financial advice.

I am sharing purely for FA interest sake and for open criticism by others of the validity of my inputs, while asking others for their valuation based thoughts for the value of IXC.

What I want from you:
For the old regular heads here who have previously discussed FA and previously have posted models - what are you thoughts on my inputs and assumptions? What do you think is reasonable? Please let me know! If you have any questions on my reasoning for certain inputs and the reasoning notes do not provide enough light, ask away in the comments.

This is THE thread for IXC fundamental chat, share thoughts about the company that can change the inputs of this valuation.

DYOR, again, I am NOT a professional, DO NOT USE this material as a reason to invest in the stock, always consult a licensed professional before investing. I am only an amateur investor who is keen to know how biotech stocks are valued and have had a stab at IXC.
Treat this as a rough draft by an amateur, do not take as gospel or as financial advice.

Expand

Not sure what software this is but is there a way you can send the document itself, is a tad tough to read it with the photo you sent, if not all good

IXC Price at posting: 54.0¢ Sentiment: Buy Disclosure: Held
3 Upvote

0 Great analysis

Reply

Top Stories

Trump just dropped a 200% tariff bomb. Here's how to cash in

VMM

'Big tick': Viridis positions for global leadership with Colossus pre-feasibility study

AAU

Antilles brings Chinese ally on board to keep Neuva Sabana work chugging on

LIS

'Opens doors': Li-S Energy the first Oz company to produce lithium metal foils

CWX

Carawine faces Fraser Range JV collapse as IGO moves to scrap partnership

Listen: HotCopper Wire Podcast 017 – RBA holds the toppings

AII

Inside the depths of Panasqueira: A legacy carved in rock

Week 28 Wrap: Tariff chaos back for some reason; CBA holds strong

ILU

Rare earths stocks surge as Pentagon buys big stake in US REE miner

HotCopper Highlights: RIP to Botanix (for now); Droneshield new ATH; Trigg mystery halt

There are more pages in this discussion • 2 more messages in this thread...

First 4 Last

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

(20min delay)
Last 9.0¢		Change 0.000(0.00%)		Mkt cap ! $6.763M

Open	High	Low	Value	Volume
0.0¢	0.0¢	0.0¢	$0	0

Buyers (Bids)

No.	Vol.	Price($)
1	41290	8.8¢

Sellers (Offers)

Price($)	Vol.	No.
9.9¢	59180	2

View Market Depth

No.	Vol.	Price($)
1	41290	0.088
1	42086	0.083
1	40000	0.075
1	16666	0.060
1	20000	0.050

Price($)	Vol.	No.
0.099	59180	2
0.105	50000	1
0.150	713	1
0.000	0	0
0.000	0	0

Last trade - 16.21pm 11/07/2025 (20 minute delay)

IXC (ASX) Chart

Day chart unavailable

DCF Valuation Model for Invex Therapeutics, page-4

Trump just dropped a 200% tariff bomb. Here's how to cash in

'Big tick': Viridis positions for global leadership with Colossus pre-feasibility study

Antilles brings Chinese ally on board to keep Neuva Sabana work chugging on

'Opens doors': Li-S Energy the first Oz company to produce lithium metal foils

Carawine faces Fraser Range JV collapse as IGO moves to scrap partnership

Listen: HotCopper Wire Podcast 017 – RBA holds the toppings

Inside the depths of Panasqueira: A legacy carved in rock

Week 28 Wrap: Tariff chaos back for some reason; CBA holds strong

Rare earths stocks surge as Pentagon buys big stake in US REE miner

HotCopper Highlights: RIP to Botanix (for now); Droneshield new ATH; Trigg mystery halt

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

DCF Valuation Model for Invex Therapeutics, page-4

Top Stories

Trump just dropped a 200% tariff bomb. Here's how to cash in

'Big tick': Viridis positions for global leadership with Colossus pre-feasibility study

Antilles brings Chinese ally on board to keep Neuva Sabana work chugging on

'Opens doors': Li-S Energy the first Oz company to produce lithium metal foils

Carawine faces Fraser Range JV collapse as IGO moves to scrap partnership

Listen: HotCopper Wire Podcast 017 – RBA holds the toppings

Inside the depths of Panasqueira: A legacy carved in rock

Week 28 Wrap: Tariff chaos back for some reason; CBA holds strong

Rare earths stocks surge as Pentagon buys big stake in US REE miner

HotCopper Highlights: RIP to Botanix (for now); Droneshield new ATH; Trigg mystery halt

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News